Financing, Equity Capital Markets
Immunovant, Inc.
09/23
|
$322.0 Million
![Immunovant](/sites/default/files/images/custom/Immunovant.png)
Piper Sandler served as bookrunner for Immunovant, Inc. on a follow-on offering and PIPE offering